Cardiovascular safety profile of duloxetine in patients with diabetic peripheral neuropathic pain

被引：0
|
作者：
Kajdasz, D. K.
Walker, D. J.
Raskin, J.
Wernicke, J. F.
Skljarevski, V.
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Eli Lilly Canada, Lilly Res Labs, Scarborough, ON, Canada
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [31] Duloxetine in the management of diabetic peripheral neuropathic pain (DPNP): Temporal profile of treatment emergent adverse events
    Schoenberger, E
    Robinson, M
    Shen, SY
    Gonzales, J
    Myers, T
    Brunton, S
    NEUROLOGY, 2006, 66 (05) : A203 - A204
  • [32] Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
    Zilliox, Lindsay
    Russell, James W.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2010, 3 : 7 - 17
  • [33] A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain
    King, Jordan B.
    Schauerhamer, Marisa B.
    Bellows, Brandon K.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1163 - 1175
  • [34] The cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK
    Beard, S.
    McCrink, L.
    Le, T. K.
    JOURNAL OF NEUROLOGY, 2006, 253 : 85 - 85
  • [35] Evaluation of functional outcomes: Duloxetine in the treatment of diabetic peripheral neuropathic pain
    Chappell, A. S.
    Wong, C. K.
    Russell, J. M.
    Backonja, M. M.
    D'Souza, D. N.
    Ferdinand, S. J.
    Le, T. K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 224 - 224
  • [36] Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK
    Beard, S. M.
    McCrink, L.
    Le, T. K.
    Garcia-Cebrian, A.
    Monz, B.
    Malik, R. A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (02) : 385 - 399
  • [37] Duloxetine for the management of diabetic peripheral neuropathic pain: Evaluation of functional outcomes
    Armstrong, David G.
    Chappell, Amy S.
    Le, Trong K.
    Kajdasz, Daniel K.
    Backonja, Miroslav
    D'Souza, Deborah N.
    Russell, James M.
    PAIN MEDICINE, 2007, 8 (05) : 410 - 418
  • [38] Evaluation of functional outcomes: Duloxetine in the treatment of diabetic peripheral neuropathic pain
    Chappell, AS
    Wong, K
    Russell, JM
    Backonja, M
    D'Souza, D
    Le, TK
    DIABETES, 2005, 54 : A125 - A126
  • [39] Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain
    Ziegler, Dan
    Pritchett, Yili L.
    Wang, Fujun
    Desaiah, Durisala
    Robinson, Michael J.
    Hall, Jerry A.
    Chappell, Amy S.
    DIABETES CARE, 2007, 30 (03) : 664 - 669
  • [40] Duloxetine in treatment of diabetic neuropathic pain
    Wernicke, JF
    Lu, YL
    Andorn, A
    D'Souza, DN
    Tran, P
    Waninger, A
    ANNALS OF NEUROLOGY, 2004, 56 : S51 - S51
12345